ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology (Q34830023)

From Wikidata

Jump to navigation Jump to search

scientific article

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the

Language	Label	Description	Also known as
English	ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology	scientific article	ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the (English)

1 reference

Europe PubMed Central

4 August 2017

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology (English)

reason for preferred rank

most precise value

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

corrigendum / erratum

Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’[Eur Heart J 2008;29:2388–2442 and Eur J Heart Fail 2008;10:933–989]

0 references

Kenneth Dickstein

1

object named as

Kenneth Dickstein

0 references

Piotr Ponikowski

object named as

Piotr Ponikowski

5

0 references

10

object named as

Arno W Hoes

1 reference

Europe PubMed Central

4 August 2017

Gerasimos Filippatos

3

object named as

Gerasimos Filippatos

1 reference

Europe PubMed Central

4 August 2017

Alexandre Mebazaa

12

object named as

Alexandre Mebazaa

1 reference

Europe PubMed Central

4 August 2017

Alain Cohen-Solal

2

object named as

Alain Cohen-Solal

1 reference

Europe PubMed Central

4 August 2017

9

object named as

Dan Atar

1 reference

Europe PubMed Central

4 August 2017

15

object named as

Karl Swedberg

1 reference

Europe PubMed Central

4 August 2017

Dirk J van Veldhuisen

8

object named as

Dirk J van Veldhuisen

1 reference

Europe PubMed Central

4 August 2017

4

object named as

John J V McMurray

1 reference

Europe PubMed Central

4 August 2017

Anna Strömberg

7

object named as

Anna Strömberg

1 reference

Europe PubMed Central

4 August 2017

ESC Committee for Practice Guidelines (CPG)

16

object named as

ESC Committee for Practice Guidelines (CPG)

1 reference

Europe PubMed Central

4 August 2017

11

object named as

Andre Keren

1 reference

Europe PubMed Central

4 August 2017

author name string

Philip Alexander Poole-Wilson

6

1 reference

Europe PubMed Central

4 August 2017

Markku Nieminen

13

1 reference

Europe PubMed Central

4 August 2017

Silvia Giuliana Priori

14

1 reference

Europe PubMed Central

4 August 2017

publication date

17 September 2008

1 reference

Europe PubMed Central

4 August 2017

European Heart Journal

1 reference

Europe PubMed Central

4 August 2017

29

1 reference

Europe PubMed Central

4 August 2017

2388-2442

1 reference

Europe PubMed Central

4 August 2017

19

1 reference

Europe PubMed Central

4 August 2017

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

0 references

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Natural history of asymptomatic left ventricular systolic dysfunction in the community

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Clinical practice. Diastolic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Left ventricular diastolic dysfunction and diastolic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Diastolic heart failure: perception of the syndrome and scope of the problem

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Diastolic heart failure: a separate disease or selection bias?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Clinical epidemiology of heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Long-Term Trends in the Incidence of and Survival with Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The epidemiology of heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Incidence and aetiology of heart failure; a population-based study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Congestive heart failure in the community: trends in incidence and survival in a 10-year period.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993-2001

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The current cost of heart failure to the National Health Service in the UK.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Survival of patients with a new diagnosis of heart failure: a population based study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Outcome of heart failure with preserved ejection fraction in a population-based study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Trends in prevalence and outcome of heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Coronary artery disease as the cause of incident heart failure in the population

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Factors determining symptoms in heart failure: comparison of fast and slow exercise tests

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Exercise limitation in chronic heart failure: central role of the periphery

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Role of skeletal muscle in the syndrome of chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Correlative classification of clinical and hemodynamic function after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriate

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Socie

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Development and testing of the European Heart Failure Self-Care Behaviour Scale.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Non-compliance in patients with heart failure; how can we manage it?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Recall of lifestyle advice in patients recently hospitalised with heart failure: a EuroHeart Failure Survey analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The crucial role of patient education in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Symptoms in patients with heart failure are prognostic predictors: insights from COMET.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The effect of controlled drinking in alcoholic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Wasting as independent risk factor for mortality in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Usefulness of a history of tobacco and alcohol use in predicting multiple heart failure readmissions among veterans

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Recommendations for exercise training in chronic heart failure patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The link between obstructive sleep apnea and heart failure: underappreciated opportunity for treatment

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The effect of digoxin on the quality of life in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Rosuvastatin in older patients with systolic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Lifetime Risk for Developing Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Navigating the crossroads of coronary artery disease and heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Assessment of myocardial viability in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Patient selection and echocardiographic assessment of dyssynchrony in cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Cardiac resynchronization in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Use of a continuous-flow device in patients awaiting heart transplantation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Ventricular assist devices for durable support

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Rhythm control versus rate control for atrial fibrillation and heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Single-chamber ventricular pacing increases markers of left ventricular dysfunction compared with dual-chamber pacing.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The progression from hypertension to congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Diabetes, left ventricular systolic dysfunction, and chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Impact of diabetes mellitus on long-term survival in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Renal impairment and outcomes in heart failure: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Heart failure and chronic obstructive pulmonary disease: An ignored combination?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Expert consensus document on beta-adrenergic receptor blockers

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Striking Similarities in Systemic Factors Contributing to Decreased Exercise Capacity in Patients With Severe Chronic Heart Failure or COPD

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Anemia as a risk factor and therapeutic target in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Etiology of anemia in patients with advanced heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Eisenmenger syndrome. Factors relating to deterioration and death

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

An introduction to acute heart failure syndromes: definition and classification

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Acute heart failure syndromes: current state and framework for future research

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Nationwide survey on acute heart failure in cardiology ward services in Italy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Combination diuretic treatment in severe heart failure: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

The acute vascular effects of frusemide in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Intravenous vasodilator therapy in congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Financial aspects of heart failure programs of care

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Disease management programmes for older people with heart failure: crucial characteristics which improve post-discharge outcomes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

How much responsibility should heart failure nurses take?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Discharge education improves clinical outcomes in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Consensus statement: Palliative and supportive care in advanced heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European S

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN309

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHN309

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34830023&oldid=1857293813"